Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Animal Models Poster
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Etiology and Pathogenesis Poster
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Treatment Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0049: Enhanced Src Homology Region 2 Domain-containing Phosphatase 1 Activity Ameliorates Murine Inflammatory Arthritis Through the Innate Immune System
    Location: Hall F1
    Abstract Poster Presenter: Adrienn Markovics, MD, PhD – Rush University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0050: TL1A expression is upregulated in rheumatic diseases and anti-TL1A antibody reduces disease symptoms and pathological changes in rat collagen-induced arthritis
    Location: Hall F1
    Abstract Poster Presenter: Andy Spencer, PhD – Spyre Therapeutics
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0051: Spp1+ Macrophages Are Specifically Enriched in Arthritic Joints and Associated with Abnormal Bone Metabolism in Collagen-Induced Arthritis Mice
    Location: Hall F1
    Abstract Poster Presenter: Chenjia He, MD – West China Hospital, Sichuan University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0052: Profiling of MT-3534, a Humanized Monoclonal Antibody Targeting Peptidylarginine Deiminase 4, as a Candidate Drug for the Treatment of RA
    Location: Hall F1
    Abstract Poster Presenter: Hisae Niki, MSc – Mitsubishi Tanabe Pharma Corporation
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0053: The Integrin Inhibitor Cilengitide Targets CCN1-Mediated Angiogenesis and Reduces Disease Severity in a Preclinical Rheumatoid Arthritis Model
    Location: Hall F1
    Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0054: Microbial Cues Promote Arthritis and Alter T Cell Selection in SKG Mice
    Location: Hall F1
    Abstract Poster Presenter: Judith Ashouri-Sinha, MD (she/her/hers) – University of California, San Francisco
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0055: TCR Signaling Thresholds Govern Anergy and Tolerance in ZAP70 Hypomorphic Models of Autoimmune Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Judith Ashouri-Sinha, MD (she/her/hers) – University of California, San Francisco
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0056: Repository Corticotropin Injection Reduces Inflammation and Bone Turnover Markers in the Murine CIA Model
    Location: Hall F1
    Abstract Poster Presenter: Maripat Corr, MD – ucsd
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0057: TNF Inhibition with Small-molecule Agents Results in Amelioration of Inflammation Similar to that of Anti-TNF Biologics While Preserving TNFR2 Signaling and Maintaining a Suppressive Regulatory T cell Phenotype
    Location: Hall F1
    Abstract Poster Presenter: Rajesh Singh, n/a – Arcus Biosciences, inc.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0058: Training for increased inflammatory arthritis in mice is not modulated by type 1 interferon
    Location: Hall F1
    Abstract Poster Presenter: Richard Bell, PhD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0059: Formyl Peptide Receptor 1 (FPR1) Influences Arthritis Severity in a Sex- and Compartment-Specific Manner
    Location: Hall F1
    Abstract Poster Presenter: Ryan Stultz, MD, PhD – University of Washington
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0060: Dietary Management of Rheumatoid Arthritis: A Functional Investigation of the Synbiotic Medical Food, SBD121
    Location: Hall F1
    Abstract Poster Presenter: Ryan Green, Ph.D. (he/him/his) – Solarea Bio Inc
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0061: IL-22 Contributes to Autoantibody-induced Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Inflamed Synovium of a Murine Model
    Location: Hall F1
    Abstract Poster Presenter: Shinjiro Kaieda, MD, PhD – Kurume university School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0062: Neddylation as a Therapeutic Target in Autoimmune Arthritis: Evidence from SKG Mice
    Location: Hall F1
    Abstract Poster Presenter: Sho Sendo, MD, PhD (he/him/his) – Kobe University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0063: Effect of alpha-ketoglutarate on Synovial Fibroblasts-Mediated Inflammation in Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Surabhi Gautam, Ph.D. (she/her/hers) – Emory University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0064: Sclerostin from marrow adipogenic precursors is essential for bone and joint homeostasis in mice
    Location: Hall F1
    Abstract Poster Presenter: Tailin He, PhD – Shenzhen Third People's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0065: Expression and Co-Localization of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues Precedes the Development of Cardiac Fibrosis in Collagen-Induced Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Wenxian Zhou, BS – University of Nebraska Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0066: RA-required synovial tissue-resident monocyte lineage cells are comprised of three distinct subpopulations.
    Location: Hall F1
    Abstract Poster Presenter: Yidan Wang, MS – Northwestern University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0067: Identification of Neutrophil Extracellular Traps in Explanted Human Lungs with Rheumatoid Arthritis-related Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Amara Seng, MD, PhD (she/her/hers) – Cedars-Sinai Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0068: Unique Fibroblast-like Synoviocyte Phenotype with Elevated MCSF Expression Induced by TLR5 Activation in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Aryan Patel, BA – University of Illinois at Chicago
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0069: Spatial transcriptomics in rheumatoid arthritis (RA) synovium reveals distinct region-specific fibroblast functions
    Location: Hall F1
    Abstract Poster Presenter: Camilla Machado, PhD – UCSD
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0070: Integrating Synovial Protein Signatures and Serum Profiles to Predict Disease Activity and Treatment Response in Early Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Chary Lopez-Pedrera, PhD – IMIBIC - Reina Sofia Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0071: Unravelling Transcriptomic Landscapes in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Shared and Unique Molecular Signatures related to relevant clinical features.
    Location: Hall F1
    Abstract Poster Presenter: Chary Lopez-Pedrera, PhD – IMIBIC - Reina Sofia Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0072: Impact of Baricitinib on Cardiovascular Health in Biologic-naïve Rheumatoid Arthritis patients: A Comparative Study with TNF Inhibitors and Conventional DMARDs
    Location: Hall F1
    Abstract Poster Presenter: Chary Lopez-Pedrera, PhD – IMIBIC - Reina Sofia Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0073: HLA-DQA1*01:02 Is Associated With IgG Multi-Reactivity With Citrulline-Containing Type II Collagen Epitopes While HLA-DRB*04:01 Is Associated With More Private Reactivity With Citrulline-Containing IgG Epitopes In Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Courtney Myhr, MS – University of Wisconsin-Madison
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0074: Rheumatoid Factors (RFs) in RA Patient Sera Do Not Bind To Fc-Free Certolizumab Pegol, But Do Bind To Fc-Containing Anti-TNF-α Biological DMARDs, Driving Immune Complex Formation and Cellular Clearance
    Location: Hall F1
    Abstract Poster Presenter: David Humphreys, PhD;BSc (he/him/his) – UCB Pharma
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0075: Impact of CXCL2 and IL-11 from Rheumatoid Arthritis Synovial Fibroblasts on Angiogenesis and Endothelial Cell Network Formation
    Location: Hall F1
    Abstract Poster Presenter: Elena Neumann, PhD (she/her/hers) – JLU Gießen, Campus Kerckhoff
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0076: Antibodies to Malondialdehyde-acetaldehyde Are Associated with Circulating Inflammatory Mediators During the Preclinical Stages of Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Emma Weis, BS – University of Nebraska Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0077: Transformer-based multi-omics study identifies important role of glycine, serine and threonine metabolism pathway in rheumatoid arthritis complicated by anemia
    Location: Hall F1
    Abstract Poster Presenter: Fanxin Zeng, PhD – Departmant of Clinical Research Center, Sichuan Clinical Research Center for Medical Imaging, Dazhou Central Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0078: Citrullinated Serum Albumin Is Not an Autoantigen in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Farheen Sultan Shaikh, PhD (she/her/hers) – University of Washington
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0079: Association of Protein Arginine Deiminase 4 with the myosin-9 Motor Complex
    Location: Hall F1
    Abstract Poster Presenter: Fatemeh (Neela) Moadab, MD (she/her/hers) – University of Washington
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0080: The Role of DICAM in Modulating Macrophage Differentiation and Inflammatory Responses via αvβ3 Integrin Signaling in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: HANNA LEE, MD – Changwon Gyeongsang National University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0081: Trans-endothelial Trafficking of Fibroblast-like Synoviocytes Amplifies Synovial Inflammation in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Jaeyeon Kim, PhD – Cedars Sinai Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0082: IBI3011, a Humanized anti-IL1RAP Monoclonal Antibody, Inhibits IL1, IL33, IL36-driven Inflammation Pathway, and Attenuates Inflammation in Preclinical Inflammatory Disease Model
    Location: Hall F1
    Abstract Poster Presenter: Jinyang Li, PhD (he/him/his) – Innovent Biologics (Suzhou) Co., Ltd.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0083: Confirmatory Factor Analysis of the Plutchik Suicide Risk Scale in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Juliana Muñoz Bedoya, MD – Juan N Corpas University Foundation
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0084: Regulation of the same chemokine gene transcription by different histone lysine methyltransferases, MLL1 and MLL3, in rheumatoid arthritis synovial fibroblasts
    Location: Hall F1
    Abstract Poster Presenter: Keita Okamoto, MD;PhD – Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0085: Single Cell RNA-seq Revealed Immune/epithelial Cell Abnormalities Underlying the Pathogenesis of Rheumatoid Arthritis-related Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Kensuke Suga, PhD – Cedars-Sinai Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0086: Androgen Upregulates Interferon Signaling in Osteoclast Differentiation During Inflammatory State
    Location: Hall F1
    Abstract Poster Presenter: Kiana Chen, PhD – University of Rochester School of Medicine and Dentistry
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0087: Integrative Metabolomic and Inflammatory Profiling in Rheumatoid Arthritis: Disease activity, therapeutic modulation, and underlying hepatic mechanisms
    Location: Hall F1
    Abstract Poster Presenter: Laura Muñoz-Barrera, BSc – IMIBIC/Reina Sofia Hospital/University of Cordoba
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0088: Imbalance of Inflammation-Regulating Microorganisms and Predicted Metabolomic Pathways Associates With Disease Evolution in Individuals At-Risk for Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Lyndsey Cole, MD – University of Colorado School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0089: Expansion of PD-1hi Tfh and Tph cells in the peripheral blood of seropositive clinically suspect arthralgia patients: association with progression to rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Maria-Eugenia Miranda-Carus, MD,PhD (she/her/hers) – Hospital Universitario La Paz
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0090: Interleukin-36β modulates the progression of rheumatoid arthritis by altering the behavior of rheumatoid arthritis synovial fibroblasts
    Location: Hall F1
    Abstract Poster Presenter: Marie Kümmel, MS (she/her/hers) – Justus-Liebig University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0091: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Rheumatoid Arthritis: associations with treatment response and comorbidities
    Location: Hall F1
    Abstract Poster Presenter: Mihir Wechalekar, MD, PhD, FRACP – Flinders Medical Centre and Flinders University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0092: SynovAI: A Revolutionary AI Framework for Enhanced Detection and Differentiation of Rheumatoid Arthritis, Osteoarthritis, and Spondyloarthritis via Advanced Ultrasound Imaging
    Location: Hall F1
    Abstract Poster Presenter: Mojtaba S. Fazli, PhD – Stanford University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0093: Soluble CD13 engages protease-activated receptor 4 to promote synovial inflammation and angiogenesis in rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Eliza Pei-Suen Tsou, PhD (she/her/hers) – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0094: Distinct immune-molecular signatures modulated ex vivo by JAK and TNF predict Rheumatoid Arthritis therapy outcomes in patients naïve to biologic and targeted synthetic DMARDs
    Location: Hall F1
    Abstract Poster Presenter: Sagrario Corrales Díaz-Flores, -None- – IMIBIC
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0095: Effect of JAK Inhibitors on Osteoblast Differentiation
    Location: Hall F1
    Abstract Poster Presenter: Toshihiro Tanioka, PhD – Showa Medical University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0096: GLUT1-Dependent Targeting and Enhanced Selectivity of a Glucose-Methotrexate Conjugate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
    Location: Hall F1
    Abstract Poster Presenter: Wojciech Tański, MD, PhD (he/him/his) – Wrocław University of Science and Technology
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0097: Aberrant Histone Marks Increase the Inflammatory Phenotype of Rheumatoid Arthritis Fibroblast-like Synoviocytes (RA FLS) by Suppressing NUB1 Induction
    Location: Hall F1
    Abstract Poster Presenter: Yosuke Ono, PhD – UCSD
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0430: Retrospective evaluation of the clinical impact of democgraphic , serological , clinical , radiological parameters and treatment modalities in patients with RA-ILD
    Location: Hall F1
    Abstract Poster Presenter: ender terzioglu, MD – Akdeniz University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0431: Calprotectin Serum levels: a potential neutrophil activation biomarker to monitor treatment response in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Eric Meldrum, PhD – Citryll BV
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0432: Frequency and Characteristics of Ophthalmologic Involvement in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Joan Manuel Dapeña, Sr, MD (he/him/his) – Sanatorio Dr. Julio Mendez
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0433: In-hospital outcomes of patients admitted due to First-Time Pulmonary Embolism with preexisting Rheumatoid Arthritis: A Nationwide Analysis 2016-2022
    Location: Hall F1
    Abstract Poster Presenter: Karuna Bista, MD (she/her/hers) – Montefiore New Rochelle Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0434: The advantage of a “tight control” and “treat-to-target” strategy in new-onset rheumatoid arthritis patients in daily rheumatology practice
    Location: Hall F1
    Abstract Poster Presenter: Meliha Kapetanovic, MD,PhD – Lund University, Department for clinical sciences Lund, section of rheumatology and Lund University Hospital Lund and Malmö
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0436: Why Do Patients with Rheumatic Disease Have MACE and Thrombotic Events?
    Location: Hall F1
    Abstract Poster Presenter: Andrea Mazariego, BA (she/her/hers) – Desert Medical Advances
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0437: Lipid Screening in Rheumatoid Arthritis: A Retrospective Cohort Study Highlighting Gaps in Cardiovascular Risk Prevention
    Location: Hall F1
    Abstract Poster Presenter: Anokhi Saklecha, MD – Yale School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0438: Exploring the Potential for Cardiorenal-Metabolic Therapies to Target Comorbidities in Early Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Bindee Kuriya, MD, MS – University of Toronto - Toronto
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0439: Osteoarthritis and Other Degenerative Musculoskeletal Disorders Are Common and Often Associated with Active Inflammation in Difficult-to-Treat Rheumatoid Arthritis: A Cross-Sectional Cohort
    Location: Hall F1
    Abstract Poster Presenter: Blanche QUERE, resident (she/her/hers) – CHU de Nantes
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0440: The Painful Truth: Non-Articular Pain's Impact on Rheumatoid Arthritis Assessment after Initiating a new DMARD for Active Disease
    Location: Hall F1
    Abstract Poster Presenter: Charis Meng, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0441: Charting the Course of Worsening: Utilizing Standard Outcomes to Define Worsening for Pathophysiological Insights into RA
    Location: Hall F1
    Abstract Poster Presenter: Charis Meng, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0443: Association Between Pan-immune-inflammation and Synovitis as Assessed by Ultrasound in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Elvira Aguilar-Oliva, DM (she/her/hers) – National Institute of Cardiology "Ignacio Chávez", Mexico City, Mexico
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0444: Low Disease Activity: Good Enough?
    Location: Hall F1
    Abstract Poster Presenter: Emily Thoman, DO – Lankenau Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0445: GLP-1 Receptor Agonists Reduce Mortality and Cardiovascular Events in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Giorgos Loizidis, MD,RhMSUS – Thomas Jefferson University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0446: A Balancing Act: The Interplay Between Resilience and Frailty in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Hannah Brubeck, BS (she/her/hers) – VA Puget Sound Health Care System
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0447: Foot-pressure distribution method for detection of foot joint arthritis in patients with rheumatic diseases
    Location: Hall F1
    Abstract Poster Presenter: Hayagrivas Manicka Bharathkumar, -None- (he/him/his) – All India Institute of Medical Sciences New Delhi
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0448: Implementing Artificial Intelligence to Identify Rheumatoid Arthritis Flares Using Electronic Medical Records Processed with Privacy-Preserving Large Language Models: A Pilot Study
    Location: Hall F1
    Abstract Poster Presenter: Ioannis Koulas, MD, MSc – Jacobi Medical Center/Albert Einstein College of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0449: Consistency of CDAI Low-Disease Activity (LDA) Outcomes with Time in a Large US Registry: Association With Patient-Reported Clinical Outcomes and Measures of Quality of Life
    Location: Hall F1
    Abstract Poster Presenter: Joel Kremer, MD – The Corrona Research Foundation
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0450: The Fibrosis-4 Index (FIB-4) Correlates with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Jose María Viotti Serra, MD (he/him/his) – Hospital Universitario de Canarias
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0451: Menopause Status and Disease Activity in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Katherine Bracamontes, MD (she/her/hers) – UCLA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0452: Ten-Year Real-World Longitudinal Analysis of Bone Mineral Density in Rheumatoid Arthritis: Impact of RA and Osteoporosis Treatments
    Location: Hall F1
    Abstract Poster Presenter: Keigo Hayashi, MD, PhD, MPH – Okayama University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0453: Safety of DMARDs in Rheumatoid Arthritis: A Nationwide Study of ILD Risk and Outcomes in RA-ILD
    Location: Hall F1
    Abstract Poster Presenter: Kyung Ann Lee, MD, PhD (she/her/hers) – Soonchunhyang University Hospital Seoul: Soonchunhyang University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0454: Models to predict flare and sustained remission in Rheumatoid Arthritis patients on optimization treatment with bDMARDs: clinical and molecular insights
    Location: Hall F1
    Abstract Poster Presenter: Laura Galindo Domínguez, -None- (she/her/hers) – Universidade Da Coruña
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0455: Assessment of Pain Outcomes in Pooled Phase 3 Trials of a Selective, Tyrosine Kinase 2 Inhibitor, Deucravacitinib, in Patients with Active Psoriatic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0456: Impact of Rheumatoid Arthritis on mortality and other outcomes in Heart failure: A nationwide analysis.
    Location: Hall F1
    Abstract Poster Presenter: Nisha Sapkota, MD – One Brooklyn Health- Interfaith Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0457: Pulmonary Profiles: Characterizing Lung Findings in Rheumatoid Arthritis Patients Undergoing Lung Cancer Screening
    Location: Hall F1
    Abstract Poster Presenter: Pratyusha Banik, MD (she/her/hers) – UW Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0459: Risk Factors for Acute Exacerbation in Patients with Rheumatoid Arthritis-associated Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Rinko Katsuda, MD (she/her/hers) – NHO Himeji Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0460: The Impact of Early and Artificial Menopause on Dementia Risk Among Women with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Ryan Salama, BA – University of Minnesota Twin Cities
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0461: Right Diagnoses For the Wrong Reasons: Limitations of Current Large-Language Model based Agentic Frameworks for Screening of Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Sarthak Verma, MD (he/him/his) – Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0462: Does Biological Sex Affect Mortality in Frail Patients with Rheumatoid Arthritis?
    Location: Hall F1
    Abstract Poster Presenter: Sayuli Bhide, MD (she/her/hers) – Pacific Medical Centers
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0463: Synovial fluid is a robust biomarker of synovial tissue inflammation in rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Solana Cushing, BA – Icahn School of Medicine at Mount Sinai
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0464: Synovial Inflammation is not Associated With Reoperation in Patients With Rheumatoid Arthritis Undergoing Total Hip or Knee Arthroplasty
    Location: Hall F1
    Abstract Poster Presenter: Solana Cushing, BA – Icahn School of Medicine at Mount Sinai
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0465: Reproductive Factors and Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease or Bronchiectasis in Women
    Location: Hall F1
    Abstract Poster Presenter: Suchita Nety, PhD – Harvard Medical School
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0466: Pilot Study Demonstrates Altered Intestinal Mucosal Microbiome in Patients with Rheumatoid Arthritis versus Control Subjects
    Location: Hall F1
    Abstract Poster Presenter: Tulsi Joishy, PhD – Vanderbilt University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0467: A Machine Learning Classifier Leveraging anti-ra33, anti-pad4, and Conventional Biomarkers Enhances Diagnostic Performance Characteristics for RA
    Location: Hall F1
    Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0468: Performance of the expanded cardiovascular risk prediction score for rheumatoid arthritis (ERS-RA) in a nationwide multicenter Chinese cohort
    Location: Hall F1
    Abstract Poster Presenter: Xingbei Dong, BS (she/her/hers) – Peking union medical college hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0469: Evaluating Large Language Models for Automated Joint Involvement Analysis in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Xingyi Liu, PhD – Mayo Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0470: Characterization of Patients With Rheumatoid Arthritis Based on Distinct Patterns of Pain Improvement Following Treatment With Filgotinib: A Post Hoc Analysis of FINCH 1
    Location: Hall F1
    Abstract Poster Presenter: Bruno Fautrel, MD, PhD – Sorbonne University - APHP
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0471: An Open-label, Randomized, Controlled Phase 1/2 Study to Assess the Safety and Efficacy of KYV-101 anti-cd19 CAR-T Cell Therapy in Active and Difficult-to-treat ACPA Positive Rheumatoid Arthritis: Preliminary Results of the COMPARE Trial
    Location: Hall F1
    Abstract Poster Presenter: Ioanna Minopoulou, MD;MSc – Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0472: Detrimental Effects of Umbilical Cord Blood-derived Mesenchymal Stem Cells Intra-articular Injections on Pannus Invasiveness
    Location: Hall F1
    Abstract Poster Presenter: Kichul Shin, MD, PhD – Seoul National University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0473: A Phase 2b Dose-ranging Study of Peresolimab for Adults With ra
    Location: Hall F1
    Abstract Poster Presenter: Michael Weinblatt, MD – Brigham and Women's Hospital/ Harvard Medical School
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0474: Real-World Experience of Janus Kinase Inhibitors; Retention and Factors Associated with Discontinuation
    Location: Hall F1
    Abstract Poster Presenter: Patrick Kiely, MD,PhD,MBBS,BSc,FRCP (he/him/his) – St George's University Hospitals NHS Foundation Trust
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0475: Drug Discontinuation in Inflammatory Arthritis Following Mandatory Non-Medical Switching from Originator to Biosimilar in Quebec, Canada
    Location: Hall F1
    Abstract Poster Presenter: Sasha Bernatsky, MD,PhD – Research Institute of the McGill University Health Centre
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0476: Impact of Comorbidity Burden on the Efficacy of, a Direct Interleukin 6 Inhibitor, Olokizumab: Real World Evidence
    Location: Hall F1
    Abstract Poster Presenter: Sofia Kuzkina, MD (she/her/hers) – R-Pharm
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0477: At the patient level, ultrasound evaluation during the follow up of rheumatoid arthritis does not modify radiographic evolution: a prospective, multicenter, randomized, pragmatic clinical trial (BCD study)
    Location: Hall F1
    Abstract Poster Presenter: Alexandre GARMENDIA, MD – Université de bretagne occidentale
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0478: Racial and Ethnic Disparities in DMARD Use and in Medicare Part B-Covered Options Among Medicare Beneficiaries with Late-Onset Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Ashkan Ara, MD, MPH – UCLA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0479: Risk of Arrhythmias Following IL-6 Inhibitor Use; A Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS)
    Location: Hall F1
    Abstract Poster Presenter: Asim Khanfar, MD – Rochester General Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0480: Efficacy and safety of tacrolimus and its serum concentration in patients with rheumatoid arthritis with inadequate response to methotrexate
    Location: Hall F1
    Abstract Poster Presenter: Chan-Bum Choi, MD, PhD, MPH (he/him/his) – Hanyang University Hosptial for Rheumatic Diseases
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0481: Intracellular Methotrexate Polyglutamate Profiles Do Not Correlate with Early Clinical Response in Treatment-Naïve Rheumatoid Arthritis: A Prospective Study
    Location: Hall F1
    Abstract Poster Presenter: Chandrashekara MN, DM – PGIMER
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0482: R-2487, a Synthetic Biology-Based Oral Immunotherapy, Promotes Treg-Mediated Immune Rebalancing and Reduces Disease Activity in Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Christian Furlan Freguia, PhD (he/him/his) – Rise Therapeutics
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0483: Safety of JAK inhibitors (JAKi) in chronic inflammatory arthritis (CIA): an observational study
    Location: Hall F1
    Abstract Poster Presenter: Clara De Miguel, MD – Hospital Clínico San Carlos
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0484: Comparable Efficacy of FK-Tocilizumab and Reference Tocilizumab in Rheumatoid Arthritis Patients With and Without Prior Biologic Exposure
    Location: Hall F1
    Abstract Poster Presenter: Ernest Choy, MD – Cardiff University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0485: Multicenter study on the use of Upadacitinib: Results in RA patients previously treated with Baricitinib
    Location: Hall F1
    Abstract Poster Presenter: Guillermo Gonzalez Mozo de Rosales, MD – Basurto University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0486: Safety of sarilumab in more than 1000 patients with rheumatoid arthritis in Japan by age group: a post-marketing surveillance study
    Location: Hall F1
    Abstract Poster Presenter: Hideto Kameda – Toho University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0487: Efficacy of sarilumab in patients with rheumatoid arthritis of different disease activity at treatment initiation: a post-hoc analysis of a Phase 3 trial of sarilumab in Japan
    Location: Hall F1
    Abstract Poster Presenter: Hideto Kameda – Toho University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0488: Early and Sustained Improvements in Disease Activity and Patient-Reported Outcomes in Patients Treated with Filgotinib for Rheumatoid Arthritis: Up to 2-Year Interim Real-World Data From FILOSOPHY and PARROTFISH
    Location: Hall F1
    Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0489: Efficacy and safety profile of JAK inhibitors in current practice in rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0490: Infection Risks Associated with Monotherapy and Combination Therapies Using Biological or Targeted - DMARD in RA: A Systematic Review and Network Meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Jia Li, MD, PhD (she/her/hers) – Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0491: Association Of short Chain Fatty Acids and diet with Disease Activity and Methotrexate Response in New Onset Rheumatoid Arthritis: A Proof of Principle Study
    Location: Hall F1
    Abstract Poster Presenter: Kaci French, MD, MPH – NYU Langone Health
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0492: Outcomes of Total Knee Replacement in Patients with Rheumatoid Arthritis: A National Inpatient Sample Database Analysis
    Location: Hall F1
    Abstract Poster Presenter: karun Shrestha, MD – Department of Internal Medicine, St. Barnabas Hospital, SBH Health System, Bronx, NY 10457, USA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0493: Phase I Trial in Participants with Rheumatoid Arthritis and Healthy Volunteers with CIT-013, a First in Class NETosis Inhibitor
    Location: Hall F1
    Abstract Poster Presenter: Maarten Kraan, MD, PhD (he/him/his) – CDS Advies BV
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0494: LFD-200, an Antibody Drug Conjugate that Selectively Delivers a Glucocorticoid Payload to Immune Cells, Provides Sustained Anti-inflammatory Effects Without Systemic Toxicity in Non-human Primates
    Location: Hall F1
    Abstract Poster Presenter: Matthew McClure, MD – Lifordi
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0495: Effectiveness and Safety of Iguratimod with Background Methotrexate Therapy in Indian Patients with Rheumatoid Arthritis: A Randomized Double Blinded Placebo Controlled Study
    Location: Hall F1
    Abstract Poster Presenter: MIDHUN SAKRAVARTHY JALANATHAN, Jr, MD (he/him/his) – ESIC Medical College & Hospital, Sanathnagar
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0496: Certolizumab Pegol Shows a Higher Retention Rate Compared to JAK Inhibitors in Patients with Rheumatoid Arthritis, Regardless of Baseline Rheumatoid Factor Levels. A Multicenter Retrospective Study.
    Location: Hall F1
    Abstract Poster Presenter: Mitndbaim Parra Moreno, MD – Reina Sofia University Hospital, Cordoba
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0497: Drug Survival and Discontinuation Reasons of Eight Biological Disease-Modifying Antirheumatic Drugs in 1,182 Patients with Rheumatoid Arthritis: A Retrospective Study Using the Niigata Orthopedic Rheumatoid Arthritis Database (NOSRAD)
    Location: Hall F1
    Abstract Poster Presenter: Nariaki Hao, PhD – Graduate School of Medical and Dental Sciences, Niigata, Japan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0498: Pharmacokinetic Similarity of DRL_AB, a Proposed Biosimilar Abatacept (Orencia®): Results from a Randomized, Single Dose, Double-Blind, Parallel Arm, Comparative Pharmacokinetic Study in Healthy Subjects by the Intravenous Route.
    Location: Hall F1
    Abstract Poster Presenter: Naveen Reddy MAREDDY, MD (he/him/his) – Biologics, Dr. Reddy’s Laboratories Ltd., Hyderabad, India
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0499: Olokizumab Improves Patient-Reported Outcomes in Rheumatoid Arthritis MTX-IR and TNF-IR Patients up to 106 Weeks (Results from Clinical Phase III Program)
    Location: Hall F1
    Abstract Poster Presenter: Roy Fleischmann, MD – Metroplex Clinical Research Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0500: Is Methotrexate Tapering Possible In Stable RA? Clinical Observations of Methotrexate Tapering At Two Tertiary Care Centers
    Location: Hall F1
    Abstract Poster Presenter: Sama Hajizadeh, MD – Allegheny Health Network
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0501: Phase 1b Study of SBT777101, an Engineered CAR-T-Regulatory Cell Product, in Patients With Rheumatoid Arthritis: Interim Demographics and Safety
    Location: Hall F1
    Abstract Poster Presenter: Sarah Baxter, MD, PhD (she/her/hers) – Sonoma Biotherapeutics
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0502: Real-World Comparative Safety of Tocilizumab and Sarilumab in Rheumatoid Arthritis: A Multi-Center Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Satani Sharkas, MD – Boston Medical Center - Brighton
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0503: Impact of Olokizumab on Pain in Rheumatoid Arthritis: a Meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Sofia Kuzkina, MD (she/her/hers) – R-Pharm
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0504: Spatial profiling of gene signatures in synovial tissue informs treatment strategy for Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Soon Wei Wong, PhD – College of Medicine and Public Health
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0505: Use of Upadacitinib in Real-World Clinical Practice: Patient Characteristics and Glucocorticoid-Sparing Effect
    Location: Hall F1
    Abstract Poster Presenter: Virginia Ruiz Esquide, PhD (she/her/hers) – Hospital Clinic de Barcelona
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0442: Beyond the Joints: The Impact of Non-Articular Pain on Patient-Reported Function in a Longitudinal Real-World Early RA Cohort
    Location: Hall F1
    Abstract Poster Presenter: Charis Meng, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0435: Comparative Outcomes in Seropositive and Seronegative Rheumatoid Arthritis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Ahmad Alomari, MD – UCF / North Florida Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0458: TyG-BMI Index as a Serological Biomarker for Carotid Plaque and Cardiac Function Changes in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Rebeca Polina-Lugo, MD (she/her/hers) – Division of Rheumatology, Hospital Universitario, UANL
  • Sunday, Oct 26th
    1:00 PM - 2:30 PM Central Time
    26S31: Abstracts: Rheumatoid Arthritis – Etiology and Pathogenesis
    Location: W190A-B
    Abstract Moderator: Melanie Smith, MD, PhD – Hospital for Special Surgery
    Abstract Moderator: Anna Helena Jonsson, MD, PhD – University of Colorado
     CE: 0.00
  • Sunday, Oct 26th
    1:00 PM - 1:15 PM Central Time
    0795: Molecular Stratification of Rheumatoid Arthritis Patients by Multi-Omics Integration Reveals Disease Status and Predictors of Therapeutic Response
    Location: W190A-B
    Presenting Author: Ismael Sánchez Pareja, Sr, MSc (he/him/his) – IMIBIC / Reina Sofia Hospital / University of Cordoba
  • Sunday, Oct 26th
    1:15 PM - 1:30 PM Central Time
    0796: Deciphering Synovial Fluid Immune Dysregulation in Rheumatoid Arthritis through Cytokine Profiling and Single-Cell Transcriptomics
    Location: W190A-B
    Presenting Author: Manon Lesturgie-Talarek, MD (she/her/hers) – Paris University
  • Sunday, Oct 26th
    1:30 PM - 1:45 PM Central Time
    0797: Spatial transcriptomics identifies density-sensing fibroblasts in synovial lining
    Location: W190A-B
    Presenting Author: Shideh Kazerouniian, PhD (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
  • Sunday, Oct 26th
    1:45 PM - 2:00 PM Central Time
    0798: Inhibition of Wnt Signaling Attenuates Inflammatory Arthritis Severity
    Location: W190A-B
    Presenting Author: Alisa Mueller – Stanford University & VA Palo Alto HCS
  • Sunday, Oct 26th
    2:00 PM - 2:15 PM Central Time
    0799: Citrullination of neutrophil serine proteases enhances proteolytic activity, stability and autoantigenicity in Rheumatoid Arthritis
    Location: W190A-B
    Presenting Author: Liam O'Neil, MD, MHS – University of Manitoba
  • Sunday, Oct 26th
    2:15 PM - 2:30 PM Central Time
    0800: Microbiota-Derived Indole Promotes Collagen-Induced Arthritis Type-17 Immunity through Intestinal Dendritic Cell Cytokine Production
    Location: W190A-B
    Presenting Author: Jing Li, PhD – University of Colorado Denver | Anschutz Medical Campus
  • Sunday, Oct 26th
    2:45 PM - 3:45 PM Central Time
    26S52: High-Intensity Training in Rheumatology: Impacts on Cardiovascular Health, Physical Function, and Immune Response
    Location: W184A
    Moderator: Yvonne Golightly, PhD, MS, PT – University of Nebraska Medical Center
    Moderator: Louise Thoma, PhD, DPT – University of North Carolina
    Session Coordinator: Louise Thoma, PhD, DPT – University of North Carolina
     CE: 1.00
  • Sunday, Oct 26th
    2:45 PM - 3:15 PM Central Time
    High-Intensity Exercise in Inflammatory Arthritis
    Location: W184A
    Speaker: Kim M. Huffman, MD, PhD – Duke University School of Medicine
  • Sunday, Oct 26th
    3:15 PM - 3:45 PM Central Time
    High-Intensity Exercise in Myositis and Other Rheumatic Conditions
    Location: W184A
    Speaker: Helene Alexanderson, PhD;PT (she/her/hers) – Karolinska University Hospital
  • Sunday, Oct 26th
    3:00 PM - 4:00 PM Central Time
    26S59: CARE to Test Your Knowledge: Complexities and Complications of Rheumatoid Arthritis
    Location: W375D-E
    Moderator: Joshua Baker, MD, MS – University of Pennsylvania
    Moderator: Rebecca Blank, MD, PhD – NYU
    Session Coordinator: Michael Toprover, MD – New York University Langone Health
     CE: 1.00
  • Sunday, Oct 26th
    3:00 PM - 4:00 PM Central Time
    Complexities and Complications of Rheumatoid Arthritis
    Location: W375D-E
    Speaker: James O'Dell, MD – University of Nebraska Medical Center
  • Sunday, Oct 26th
    3:00 PM - 4:30 PM Central Time
    26S68: Abstracts: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes II: Look What You Made Me Do (Prediction)
    Location: S103
    Abstract Moderator: Liam O'Neil, MD, MHS – University of Manitoba
    Abstract Moderator: John Davis, III, MD, MS, RhMSUS – Mayo Clinic
     CE: 0.00
  • Sunday, Oct 26th
    3:00 PM - 3:15 PM Central Time
    0831: Altered Expression of cd11c and HLA-DR on Monocyte Subsets in Individuals at Risk of Rheumatoid and Psoriatic Arthritis
    Location: S103
    Presenting Author: Klara Prajzlerova, PhD – Institute of Rheumatology
  • Sunday, Oct 26th
    3:15 PM - 3:30 PM Central Time
    0832: Elevated serum peptidylarginine deiminase 4 (PAD4) levels in anti-CCP antibody positive at-risk individuals with arthralgia who progress to rheumatoid arthritis.
    Location: S103
    Presenting Author: Sana Sharrack, MRCP, MBBCH – University of Leeds
  • Sunday, Oct 26th
    3:30 PM - 3:45 PM Central Time
    0833: Sputum Anti-CCP-IgA and NET-Associated Proteins Predict Risk and Timing of the Transition From Systemic Autoimmunity to Classified RA
    Location: S103
    Presenting Author: Timothy Wilson, MD – Thomas Jefferson University
  • Sunday, Oct 26th
    3:45 PM - 4:00 PM Central Time
    0834: Heterogeneity in the Association of Genetic Risk for Rheumatoid Arthritis and Resultant Rheumatoid Arthritis Phenotypes
    Location: S103
    Presenting Author: Thomas Riley, IV, MD, MSCE – University of Pennsylvania
  • Sunday, Oct 26th
    4:00 PM - 4:15 PM Central Time
    0835: IgG Glycome In Early Rheumatoid Arthritis Differs From Matched Controls and Links Less Lean Mass to an Early Aging Phenotype
    Location: S103
    Presenting Author: Sidra Hashmi, MD – Duke Molecular Physiology Institute,Duke University School of Medicine
  • Sunday, Oct 26th
    4:15 PM - 4:30 PM Central Time
    0836: Growth Differentiation Factor-15 Predicts Frailty and Death in Rheumatoid Arthritis
    Location: S103
    Presenting Author: Katherine Wysham, MD – VA PUGET SOUND/UNIVERSITY OF WASHINGTON
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M19: Abstracts: Rheumatoid Arthritis – Animal Models
    Location: S105
    Abstract Moderator: Susan MacLauchlan, PhD – Brigham and Women's Hospital
    Abstract Moderator: Maripat Corr, MD – ucsd
     CE: 0.00
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M25: From Omics to Action: Redefining the Immune Landscape in RA Joint
    Location: W375A
    Moderator: Samuel Dowling, MD;PhD – Ann & Robert H. Lurie Children's Hospital of Chicago
    Moderator: Deepak Rao, MD;PhD – Brigham and Women's Hospital
    Session Coordinator: Carla Cuda, PhD – Northwestern University
     CE: 1.50
  • Monday, Oct 27th
    10:00 AM - 10:15 AM Central Time
    0867: NLRP3 Inflammasome Impairs Fracture Repair in Rheumatoid Arthritis through RhoA/Rac1-IL1β Axis-Mediated Suppression of Osteoblast Differentiation
    Location: S105
    Presenting Author: WEN SUN, PhD – Nanjing Medical University
  • Monday, Oct 27th
    10:00 AM - 10:30 AM Central Time
    Tissue-Resident, Extravascular Ly6c- Monocytes Are Critical for Inflammation in the Synovium
    Location: W375A
    Speaker: Harris Perlman, PhD – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 10:45 AM Central Time
    0869: PD-1 inhibitor unleashes pathogenic CD8+ T cells and induce arthritis in collagen-primed mice
    Location: S105
    Presenting Author: Sang Kim, MD – Yale University
  • Monday, Oct 27th
    10:30 AM - 11:00 AM Central Time
    Fibroblast Zonation in Rheumatoid Arthritis
    Location: W375A
    Speaker: Kevin Wei, MD, PhD – Brigham and Women's Hospital at Harvard Medical School
  • Monday, Oct 27th
    10:45 AM - 11:00 AM Central Time
    0870: Same Model, Different Results: Vendor and Microbiome Influence Reproducibility in Collagen Induced Arthritis
    Location: S105
    Presenting Author: Brenda Seymour, PhD – University of Colorado
  • Monday, Oct 27th
    11:00 AM - 11:15 AM Central Time
    0871: The gut microbiome shapes MTX pharmacology and is linked to treatment outcomes
    Location: S105
    Presenting Author: Renuka Nayak, MD, PhD – University of California, San Francisco (UCSF)
  • Monday, Oct 27th
    11:00 AM - 11:30 AM Central Time
    RA Synovial Cell Types and Spatial Niches Involved in Pannus Formation
    Location: W375A
    Speaker: Laura Donlin, PhD – Hospital for Special Surgery
  • Monday, Oct 27th
    11:15 AM - 11:30 AM Central Time
    0872: Silencing of Schnurri-3 protects from TNF-induced bone loss and is accompanied by upregulation of type I Interferon-Stimulated Genes (ISGs) in osteoblasts.
    Location: S105
    Presenting Author: Priyanka Kushwaha, PhD – Brigham and Women's Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Treatment Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1306: Systematic Literature Review of Digital Sleep Outcomes and Endpoints Used to Assess Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Anna fishbein, MD – Sanofi
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1307: Plasma levels of monounsaturated fatty acids (MUFAs) positively correlate with disease activity in patients with rheumatoid arthritis (RA)
    Location: Hall F1
    Abstract Poster Presenter: Beatriz Hanaoka, MD, MSc – Oklahoma University Health Sciences Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1308: Predictors of Interstitial Lung Disease Progression in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Bryant England, MD, PhD – University of Nebraska Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1309: Transcriptomic biomarkers of progression from undifferentiated arthritis to rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Damini Jawaheer, PhD, MS – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1310: Naturalized Language Processing Based Extraction of Rheumatoid Arthritis Disease Activity Measures from the Electronic Health Record
    Location: Hall F1
    Abstract Poster Presenter: Elizabeth Park, MD, MSc – Columbia University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1311: Decade-Based Trends in First Remission Among Rheumatoid Arthritis Patients: A Population-Based Study
    Location: Hall F1
    Abstract Poster Presenter: Georges El Hasbani, MD – Mayo Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1312: Evolution of patients with active rheumatoid arthritis: analysis of disease activity trajectories in a tertiary‑care rheumatology department
    Location: Hall F1
    Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1313: Retrospective Analysis of Factors Associated With Fracture in 2855 Patients With Rheumatoid Arthritis, Stratified by Steroid Use
    Location: Hall F1
    Abstract Poster Presenter: Jonathan Barnes, MBBS – Morecambe Bay NHS Trust
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1314: Protein-Specific Anti-Malondialdehyde-Acetaldehyde Antibodies and Cardiovascular Disease Outcomes in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Julia King, BS – Creighton University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1315: High-resolution thermography and Artificial Intelligence to evaluate and classify Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Liam O'Neil, MD, MHS – University of Manitoba
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1316: Predicting mortality of rheumatoid arthritis in China: A nation-wide cohort study
    Location: Hall F1
    Abstract Poster Presenter: Kangping Huang, BSc, -None- (he/him/his) – Peking Union Medical College
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1317: The Association Between Insomnia and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 546,822 Patients
    Location: Hall F1
    Abstract Poster Presenter: Mohamed Abdelsalam, MSc, MBBCH – MUST University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1318: Diagnostic Delay in Rheumatoid Arthritis and its Impact on Radiographic Outcomes: A Systematic Review and Meta-analysis of 100,066 Patients
    Location: Hall F1
    Abstract Poster Presenter: Mohamed Abdelsalam, MSc, MBBCH – MUST University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1319: The Association of Rheumatoid Arthritis in Patients with Vitiligo: Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Nattanicha Chaisrimaneepan, MD – Texas Tech University Health Sciences Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1320: Trends In Incidence and Risk factors For Incident Venous Thromboembolism in Patients with Rheumatoid Arthritis: A Population-Based Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Noah Frechette, BS – Mayo Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1321: Efficacy and safety of janus kinase inhibitors in diffuse interstitial lung disease in rheumatoid arthritis. Systematic review
    Location: Hall F1
    Abstract Poster Presenter: Olga Compán Fernández, MD. – Rheumatology Service, University Hospital of Salamanca
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1322: High Rheumatoid Factor Titers and Biologic Persistence in RA: Beyond TNF Inhibitors
    Location: Hall F1
    Abstract Poster Presenter: Sara Salas Santamaria, MD, MEd – Hospital Universitario La Paz
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1323: Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial
    Location: Hall F1
    Abstract Poster Presenter: Sofia Kuzkina, MD (she/her/hers) – R-Pharm
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1324: Similar Negative Effects of Fatigue on Physical Activity in Persons with Rheumatoid Arthritis and Healthy Controls: A Patient-Control Study
    Location: Hall F1
    Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1325: Plasma Matrix Metalloproteinases and Heart Failure Outcomes in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Tate Johnson, MD – University of Nebraska Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1326: Association Between Physical Function and Nutritional Status in Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Yasumori Sobue, MD, PhD – Sobue Orthopedic Clinic Yatomi
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1328: Mortality Trends of Hypertension in Patients with Rheumatoid Arthritis in the United States (1999–2020)
    Location: Hall F1
    Abstract Poster Presenter: Areeba Minhaj, MD – University of South Dakota
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1329: Relationship Between Circulating Bacterial Small RNAs, Methotrexate Response, and Microbiome in New Onset Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Carolina Ramirez Becerra, MD – Vanderbilt University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1331: anti-beta-2-glycoprotein-1 Iga Antibodies Facilitate Macrophage Cholesterol Loading and Influence Coronary Atherosclerosis Progression in a Dose-dependent Manner in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: George Karpouzas, MD (he/him/his) – Harbor-UCLA Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1332: Mid‐Infrared Spectroscopy for Enhanced Diagnosis of Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Gilad Halpert, PhD – Reichman University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1333: Assessment of Lipid Abnormalities After Initiation of a JAK Inhibitor in Rheumatoid Arthritis in Clinical Practice
    Location: Hall F1
    Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1334: Cardiac Biomarkers and Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort
    Location: Hall F1
    Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1335: Chest x-Ray and pulmonary function tests are not sensitive for screening intertitial lung disease in reumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Jesús Loarce, Sr, MD – Ramón y Cajal University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1336: Effectiveness of new initiators of tofacitinib and other biologic/targeted synthetic DMARDs in patients with rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: Katherine Liao, MD, MPH – Brigham and Women's Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1337: The Association Between Glucagon-Like Peptide-1 Receptor Agonist and Rheumatoid Arthritis: A Population-Based Case Control Study
    Location: Hall F1
    Abstract Poster Presenter: Mohammad Naffaa, MD – Galilee Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1338: Short-Chain Fatty Acids and Their Gut Microbial Metabolic Pathways Distinguish Rheumatoid Arthritis in Discordant Monozygotic Twins
    Location: Hall F1
    Abstract Poster Presenter: Rebecca Blank, MD, PhD – NYU
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1339: Inflammatory Rheumatic Diseases in IDH-mutated Myeloid Neoplasms: Clinical Spectrum and Response to IDH Inhibitors
    Location: Hall F1
    Abstract Poster Presenter: Romain Stammler, n/a (he/him/his) – Assistance Publique des Hôpitaux de Paris
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1340: Does Moderate Alcohol Use Lower Disease Activity Among Patients with Rheumatoid Arthritis?
    Location: Hall F1
    Abstract Poster Presenter: Sarah Crisci, MS, MPH – Thermo Fisher Scientific
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1341: Physical Function Across Age in Patients With Rheumatoid Arthritis and Population Controls: A Cross-Sectional Study of Four Performance Measures
    Location: Hall F1
    Abstract Poster Presenter: Saskia Truijen, MSc – Maastricht University Medical Centre+
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1343: Six-Minute Walk Distance as a Functional Measure in Rheumatoid Arthritis-associated Interstitial Lung Disease Reflecting Both Lung and Joint Involvement
    Location: Hall F1
    Abstract Poster Presenter: Sung Hae Chang, MD, PhD, MPH – Soonchunhyang University College of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1344: Exploring the Factors Associated with the Discontinuation of Tofacitinib in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Yao-fan Fang, MD – Chang-Gung memorial hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1345: Upregulated TLR Signaling Identified in Difficult-to-Treat RA: A Propensity Score–Matched Transcriptome Study
    Location: Hall F1
    Abstract Poster Presenter: Yoshinori Nishiura, MD – Japan Red Cross Okayama Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1346: Preliminary Result of Investigating the Response of Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) Associated SNPs: One Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: YU Chen, MD, MSc, BA (she/her/hers) – 1. Division of Rheumatology, Allergy and Immunology, Far Eastern Memorial Hospital, New Taipei City, Taiwan, R.O.C.
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1347: The Better Disease-modifying antirheumatic drug (DMARD)? Efficacy and Safety of Methotrexate Versus Leflunomide Monotherapy in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Aakanksha Pitliya, MD (she/her/hers) – Mercy Catholic Medical Center, Darby, PA
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1348: Real World Evaluation on the Effectiveness of Baricitinib or Other Treatments in Patients With Rheumatoid Arthritis: Data from the European and Non-European Cohorts of the RA-BE-REAL Study
    Location: Hall F1
    Abstract Poster Presenter: AJ Fernandez, n/a – Eli Lilly and Company
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1349: Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study
    Location: Hall F1
    Abstract Poster Presenter: Andrew Ostor, MD – Australian National University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1350: Initial Biologic Therapy Improves Sexual Function in Female Patients with Rheumatoid Arthritis: A 6 Month Follow-Up Study
    Location: Hall F1
    Abstract Poster Presenter: Daniel Zavada, MD – Charles University, Third Faculty of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1351: Are Glucocorticoids Associated with Worse Overall Survival Among Rheumatoid Arthritis Patients Treated with Immune Checkpoint Inhibitors? The Confounding Effect of Dexamethasone
    Location: Hall F1
    Abstract Poster Presenter: Deanna Jannat-Khah, MPH, DrPH – Hospital For Special Surgery
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1352: Prediction of 5-Year Fracture Risk in Rheumatoid and Psoriatic Arthritis Using REMS Technology
    Location: Hall F1
    Abstract Poster Presenter: Edmund MacLaughlin, MD – Rheumatology Associates of Delmarva
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1353: Phase 3 Study of the Efficacy, Safety and Immunogenicity of the Proposed Tocilizumab Biosimilar RGB-19, Intravenously Administered to Participants With Active Rheumatoid Arthritis: 52-Week Data
    Location: Hall F1
    Abstract Poster Presenter: Gerd Burmester, MD – Charité - Universitätsmedizin Berlin
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1354: Effect of Ivarmacitinib on Joint Swelling and Tenderness in Patients with Moderate-to-severe Rheumatoid Arthritis: A Post-hoc Study of a Phase III Clinical Trial
    Location: Hall F1
    Abstract Poster Presenter: Hongtao Jin, MD – The Second Hospital of Hebei Medical University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1355: Use of parenteral compared to oral glucocorticoids in early rheumatoid arthritis is superior for chance ofbeing off steroids and escalation of therapy at 1 year
    Location: Hall F1
    Abstract Poster Presenter: Janet Pope, MD, FRCPC, MPH – University of Western Ontario
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1356: Use of (MSB11456), the first tocilizumab biosimilar approved for rheumatoid arthritis: 6-month data from an international observational study
    Location: Hall F1
    Abstract Poster Presenter: Jonathan Kay, MD – UMass Chan Medical School
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1357: Measuring Rheumatoid Arthritis Outcomes Using Machine Learning Imputed Disease Activity Scores
    Location: Hall F1
    Abstract Poster Presenter: Jue Hou, PhD – University of Minnesota
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1358: Real-World Evidence for the Superiority of Subcutaneous Methotrexate in RA: A Comparative Observational Study with Ultrasonographic Assessment
    Location: Hall F1
    Abstract Poster Presenter: Masatsugu Komagamine, MD, PhD – Iwate Medical University hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1359: Comparative Safety Outcomes of Tofacitinib Versus Upadacitinib in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Maya Khasho, MD – University of central florida
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1360: Evaluating Causal Effects of Biologic and Targeted Synthetic Disease-modifying Anti-rheumatic Drugs Targets in Rheumatoid Arthritis Using Mendelian Randomisation
    Location: Hall F1
    Abstract Poster Presenter: Mihye Kwon, MD, PhD (she/her/hers) – Konyang University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1361: Efficacy of Telitacicept in the treatment of Connective tissue disease-associated interstitial lung disease: A Potential therapeutic option
    Location: Hall F1
    Abstract Poster Presenter: Mingfang Sun, MD – Department of Rheumatology & Clinical Immunology, Daping Hospital & Research Institute of Surgery, Army Medical University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1362: Multimodal Spatial and Single-Cell Profiling of Synovial Tissue Reveals Macrophage Programs Associated with Biologic TherapyTreatment Response in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Mohammad Daud Khan, MS – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1363: Evaluation of the Clinical Outcome of Baricitinib in Patients with Rheumatoid Arthritis from Multi-center Collaborative Study in Japan: Sub-analysis for Difficult-to-treat RA.
    Location: Hall F1
    Abstract Poster Presenter: NAOKI Kondo, MD, PhD – Division of Orthopedic Surgery, Niigata University Medical and Dental General Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1364: Efficacy Of Ayurvedic Treatment Versus Placebo, Each In Combination With Methotrexate In Early RA Over 20 Weeks: An Exploratory Randomized Control Trial
    Location: Hall F1
    Abstract Poster Presenter: Venkatesh Srinivasa Pai, MBBS, MD,DM (he/him/his) – AIIMS RISHIKESH
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1365: Economic impact of early treatment and strict disease control in rheumatoid arthritis: a cost-minimization approach concerning biological therapy
    Location: Hall F1
    Abstract Poster Presenter: Raianni Rúbia Pacheco Silva, DSc (she/her/hers) – Universidade de Brasília
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1366: Cost Per Responder Analysis of Certolizumab Pegol Versus Adalimumab in Patients with Moderate to Severe Active Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Payer Perspective from Canada and Brazil
    Location: Hall F1
    Abstract Poster Presenter: Remi Marty, PharmD – UCB
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1367: Molecular Signature Response Classifier Identifies Contribution of GLP-1 Therapy to TNF Inhibitor Response in Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Ryan Phan, PhD (he/him/his) – Scipher Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1368: Thrombocytosis Predicts Response to Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis: Data from the Korean KOBIO Registry
    Location: Hall F1
    Abstract Poster Presenter: Sehee Kim, MD, PhD – Kyunghee university at Gangdong
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1369: Impact of SGLT2 Inhibitors and GLP-1 Agonists on RA Flares in Patients on DMARD Therapy: A Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Shreya Sakthivel, DO – Anne Arundel Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1370: Impact of Six-Month Monitoring Compared to Three-Month Monitoring of Labs for Methotrexate Toxicity
    Location: Hall F1
    Abstract Poster Presenter: Spencer Simko, MD, MPH (he/him/his) – University of Texas Southwestern
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1371: Effect of bDMARDs and tsDMARDS on diffuse interstitial lung disease associated with rheumatoid arthritis: systematic review and meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Stéphane HILLIQUIN, n/a – Département de Rhumatologie, Hôpital Cochin, Assistance publique des Hôpitaux de Paris, Université Paris-Cité, Paris, France
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1372: Treatment Patterns and Outcomes After Janus Kinase Inhibitor Discontinuation in Rheumatoid Arthritis: A Real-World Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Sungwon Ko, MD – ASAN MEDICAL CENTER
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1373: Effect of JAK Inhibitors on Bone Mineral Density in Rheumatoid Arthritis Patients with Osteoporosis: A Comparative Study with Biologics
    Location: Hall F1
    Abstract Poster Presenter: Sungwon Ko, MD – ASAN MEDICAL CENTER
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1374: AZD1163, a Novel Bispecific Human Antibody Targeting PAD2/4 Enzymes Responsible for Generating Citrullinated Protein Auto-antigens in Rheumatoid Arthritis, Demonstrates Dose-dependent Inhibition of Systemic PAD Activity in Healthy Volunteers
    Location: Hall F1
    Abstract Poster Presenter: Susanne Prothon, MSc – AstraZeneca
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1375: 86-96% of Rheumatoid Arthritis (RA) Patients with RA Who Have 0 or 1 Swollen Joint or Tender Joint but Are Classified as Moderate/high on RA Indices Have 1-9 Comorbidities Recognized on a Multidimensional Health Assessment Questionnaire (MDHAQ)
    Location: Hall F1
    Abstract Poster Presenter: Theodore Pincus, MD, FACR, MACR – Rush University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1342: The Impact of Age on Health-Related Quality of Life in Patients With Rheumatoid Arthritis Compared to Population Controls: A Cross-Sectional Analysis
    Location: Hall F1
    Abstract Poster Presenter: Saskia Truijen, MSc – Maastricht University Medical Centre+
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1330: Sex and reproductive stage modify the role of endogenous estrogens on coronary atherosclerosis in rheumatoid arthritis and differences reflect effects on inflammation and cholesterol metabolism
    Location: Hall F1
    Abstract Poster Presenter: George Karpouzas, MD (he/him/his) – Harbor-UCLA Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1327: Systematic Review of Mobility in Rheumatoid Arthritis with Digitally Measured Objective Assessment
    Location: Hall F1
    Abstract Poster Presenter: Anna fishbein, MD – Sanofi
  • Monday, Oct 27th
    1:00 PM - 2:30 PM Central Time
    27M34: Abstracts: Rheumatoid Arthritis – Treatment I: Preventative and Novel Treatments
    Location: S105
    Abstract Moderator: Rebecca Blank, MD, PhD – NYU
    Abstract Moderator: Carlos Lozada, MD – University of Miami Miller School of Medicine
     CE: 0.00
  • Monday, Oct 27th
    1:00 PM - 1:15 PM Central Time
    1674: A Phase 2, Randomized, Placebo-controlled Trial of Hydroxychloroquine in Individuals At-risk for Future Rheumatoid Arthritis
    Location: S105
    Presenting Author: Kevin Deane, MD, PhD – University of Colorado Denver Anschutz Medical Campus
  • Monday, Oct 27th
    1:15 PM - 1:30 PM Central Time
    1675: Neuroimmune modulation in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors (TNFi)
    Location: S105
    Presenting Author: Guillermo Valenzuela, MD, FACR – Guillermo Valenzuela MD PA/ IRIS Rheumatology
  • Monday, Oct 27th
    1:30 PM - 1:45 PM Central Time
    1676: Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients With Rheumatoid Arthritis: 7-Year Data From the SELECT-COMPARE Study
    Location: S105
    Presenting Author: Roy Fleischmann, MD – Metroplex Clinical Research Center
  • Monday, Oct 27th
    1:45 PM - 2:00 PM Central Time
    1677: First line anti-TNF therapy in early rheumatoid arthritis is associated with a lower frequency of difficult-to-treat disease at five years and better long-term outcomes compared with usual care
    Location: S105
    Presenting Author: Task Toyoda, MBBS, MRCP (he/him/his) – University of Leeds
  • Monday, Oct 27th
    2:00 PM - 2:15 PM Central Time
    1678: Abatacept in Individuals at Risk of Developing Rheumatoid Arthritis: Results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept Long Term Outcomes (ALTO) Study
    Location: S105
    Presenting Author: Andrew Cope, MD, PhD – King's College London
  • Monday, Oct 27th
    2:15 PM - 2:30 PM Central Time
    1679: Does First-Line b- or tsDMARDs Choice Influence Progression to Difficult-to-Treat Rhumatoid arthritis? Insights from our longitudinal RA UCLouvain Brussels cohort
    Location: S105
    Presenting Author: Francesco Natalucci, MD, PhD – UCLouvain University
  • Monday, Oct 27th
    2:30 PM - 3:30 PM Central Time
    27M57: Paul Klemperer Memorial Lecture
    Location: W375A
    Moderator: Liana Fraenkel, MD, MPH – Berkshire Medical Center
    Session Coordinator: Gregory Gardner, MD – University of Washington
     CE: 1.00
  • Monday, Oct 27th
    2:30 PM - 3:30 PM Central Time
    New Paradigms in the Immunopathogenesis of Rheumatoid Arthritis and Other Autoimmune Diseases
    Location: W375A
    Speaker: Michael Brenner, MD – Brigham and Women's Hospital, Harvard Medical School
  • Monday, Oct 27th
    3:00 PM - 4:00 PM Central Time
    27M68: Rheumatology Research Foundation Memorial Lecture: To Memorialize Dr. Joseph Croft
    Location: W375B
    Moderator: David Borenstein, MD – Retired
    Session Coordinator: Gregory Gardner, MD – University of Washington
     CE: 1.00
  • Monday, Oct 27th
    3:00 PM - 4:00 PM Central Time
    100 Years of Treating Rheumatoid Arthritis: To Create Our Future We Must Understand Our Past
    Location: W375B
    Speaker: Michael Weinblatt, MD – Brigham and Women's Hospital/ Harvard Medical School
  • Tuesday, Oct 28th
    8:30 AM - 10:00 AM Central Time
    28T09: Gastrointestinal Manifestations of Connective Tissue Diseases: Diagnosis, Treatment, and Emerging Research
    Location: W375C
    Moderator: Silvia Bellando-Randone, MD, PhD – University of Florence
    Moderator: Samuel Good, MD – University of California, Los Angeles
    Session Coordinator: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
    Session Coordinator: DeAnna Baker Frost, MD;PhD – Medical University of South Carolina
     CE: 1.50
  • Tuesday, Oct 28th
    8:30 AM - 9:00 AM Central Time
    The Impact of the Gut Microbiome in Individuals at Risk of Rheumatoid Arthritis
    Location: W375C
    Speaker: Christopher Rooney, MD, PhD, MRCP – University of Leeds, UK
  • Tuesday, Oct 28th
    9:00 AM - 9:30 AM Central Time
    Gastrointestinal Disease in Rheumatoid Arthritis: The Impact of the Gut Microbiome on Treatment
    Location: W375C
    Speaker: Renuka Nayak, MD, PhD – University of California, San Francisco (UCSF)
  • Tuesday, Oct 28th
    9:30 AM - 10:00 AM Central Time
    Nutrition and the Gut Microbiome: Dietary Modifications That May Ameliorate Gastrointestinal Symptoms in Autoimmune Rheumatic Diseases
    Location: W375C
    Speaker: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
  • Tuesday, Oct 28th
    10:00 AM - 11:30 AM Central Time
    28T16: Abstracts: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes I: Breathe (ILD/Pulmonary)
    Location: W183A-C
    Abstract Moderator: Kristen Demoruelle, MD, PhD – University of Colorado Anschutz Medical Campus
    Abstract Moderator: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
     CE: 0.00
  • Tuesday, Oct 28th
    10:00 AM - 10:15 AM Central Time
    1746: Inflammatory- and Fibrosis-Related Biomarkers and Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk
    Location: W183A-C
    Presenting Author: Bryant England, MD, PhD – University of Nebraska Medical Center
  • Tuesday, Oct 28th
    10:15 AM - 10:30 AM Central Time
    1747: Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study
    Location: W183A-C
    Presenting Author: QIANRU ZHANG, MD – Tsinghua University affiliated Beijing Tsinghua Changgung Hospital
  • Tuesday, Oct 28th
    10:30 AM - 10:45 AM Central Time
    1748: Effect of Air Pollution on Disease Activity in Patients with Rheumatoid Arthritis
    Location: W183A-C
    Presenting Author: Sung Cheol Jung, MD – Seoul National University College of Medicine
  • Tuesday, Oct 28th
    10:45 AM - 11:00 AM Central Time
    1749: External validation of a combined clinical and genetic risk score for the identification of interstitial lung disease in rheumatoid arthritis
    Location: W183A-C
    Presenting Author: Austin Wheeler, MD (he/him/his) – University of Nebraska Medical Center
  • Tuesday, Oct 28th
    11:00 AM - 11:15 AM Central Time
    1750: Urinary Proteomic Signature Identifies Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
    Location: W183A-C
    Presenting Author: Jia Shi, MD – University of Washington
  • Tuesday, Oct 28th
    11:15 AM - 11:30 AM Central Time
    1751: Disease activity, inflammation, and older age are associated with quantitative interstitial abnormalities in early RA: Results from a multicenter, prospective cohort study
    Location: W183A-C
    Presenting Author: Gregory McDermott, MD, MPH – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Rheumatoid Arthritis – Treatment Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2227: The Paraoxonase-1 Q192R Polymorphism is Associated with Increased Risk of Incident Clinical Rheumatoid Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population
    Location: Hall F1
    Abstract Poster Presenter: Amir Razmjou, MD, MSc – UCLA / GLA-VA
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2239: Increased Cardiovascular Morbidity in Patients with Rheumatoid Arthritis and Type 2 Diabetes: A Large-Scale Electronic Health Record Analysis
    Location: Hall F1
    Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2240: Diabetes Significantly Amplifies Risk of Cardiac Arrhythmias in Rheumatoid Arthritis Patients: Results from a Multi-Center Electronic Health Record Study
    Location: Hall F1
    Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2251: Dual Diagnoses, Diminished Survival: Association between rheumatoid arthritis and survival among older adults with lung cancer
    Location: Hall F1
    Abstract Poster Presenter: Michelle Nguyen, MD – University of Washington
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2253: Wrist-worn Wearable Device Data Can Be a New Digital Biomarker For Disease Activity In Rheumatoid Arthritis: a Multicenter Single-arm Prospective Study
    Location: Hall F1
    Abstract Poster Presenter: Misako Higashida-Konishi, MD – NHO Tokyo Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2265: Progressive Interstitial Lung Disease associated to Rheumatoid Arthritis despite Abatacept therapy. Data from a large national multicenter cohort of 526 patients
    Location: Hall F1
    Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2266: Impact of Rheumatoid Arthritis Therapeutic Classes on Risk of All-Cause Mortality and All-Cause Cancer: A Population-Based Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Bindee Kuriya, MD, MS – University of Toronto - Toronto
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2267: Impact of Baseline Cardiovascular Risk Factors Comorbidities on an Adalimumab Biosimilar Efficacy, Quality of Life and Safety In Patients with Patients with Moderately to Severely Active Rheumatoid Arthritis: Results from the AURIEL-RA study
    Location: Hall F1
    Abstract Poster Presenter: Christopher Edwards, MD;FRCP – University Hospital Southampton
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2268: Differential Impact of Certolizumab Pegol, Etanercept, and Adalimumab on Rheumatoid Factor Reduction and Seroconversion in Rheumatoid Arthritis: A Propensity Score–Matched Study
    Location: Hall F1
    Abstract Poster Presenter: Clementina Lopez-Medina, MD, PhD (she/her/hers) – Reina Sofia University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2269: Key factors in optimizing the dose of Baricitinib in rheumatoid arthritis: a study based on routine clinical practice and its therapeutic implications
    Location: Hall F1
    Abstract Poster Presenter: Daniel Campos-Martin, n/a (he/him/his) – Rheumatology Department, Donostia University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2270: ACKR1 and Leukopenia in Patients with Rheumatoid Arthritis Treated with Disease Modifying Antirheumatic Drugs
    Location: Hall F1
    Abstract Poster Presenter: Daniela Chavez de Paz Solis, BS (she/her/hers) – National Institutes of Health
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2271: Assessing the Real-world Impact of Earlier Initiation of Adalimumab vs. Conventional Synthetic Dmards on Healthcare Resource Utilization in Patients with Rheumatoid Arthritis in Europe
    Location: Hall F1
    Abstract Poster Presenter: Dr. Carmen Bremer, PhD – Sandoz International GmbH
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2272: Combination Therapy with TNF Inhibitors and JAK Inhibitors in Multi-Drug-Resistant Rheumatoid Arthritis: A Case Series from the RA UCLouvain Brussels Cohort
    Location: Hall F1
    Abstract Poster Presenter: Francesco Natalucci, MD, PhD – UCLouvain University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2273: Impact of Upadacitinib on Glucocorticoid Reduction in Patients with Moderate-to-Severe RA Who Achieved and Maintained Clinical Remission in the 2-Year UPHOLD Study
    Location: Hall F1
    Abstract Poster Presenter: FRANK BUTTGEREIT, MD – Charité University Medicine Berlin
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2274: Importance Of Fc Region On Therapeutic Survival In Rheumatoid Arthritis Patients With Anti-TNF Therapy
    Location: Hall F1
    Abstract Poster Presenter: Iago Alcántara Álvarez, MD – Hospital Universitari i Politènic La Fe
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2275: Agreement Between Two Rheumatoid Arthritis Response Measures Across Bts DMARD Treatment Classes in a Large, Prospective Observational Study Supporting the Development and Clinical Validation of a Novel Blood based Precision Medicine Test
    Location: Hall F1
    Abstract Poster Presenter: Jason Carlson, MPH – Aqtual Inc
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2276: Long-Term Cardiovascular Risk Following Tnfi vs Triple Therapy: A Post-hoc Analysis Integrating Randomized Clinical Trial and Electronic Health Record Data
    Location: Hall F1
    Abstract Poster Presenter: Jennifer Hanberg, MD – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2277: Immunophenotyping of peripheral blood mononuclear cells reveals potential cellular biomarkers of disease in rheumatoid arthritis
    Location: Hall F1
    Abstract Poster Presenter: John Bui, BSc – Sonoma Biotherapeutics
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2278: Neuroimmune modulation for the Treatment of Rheumatoid Arthritis: Results at 12 months from a Randomized, Sham-Controlled, Double-Blind Study
    Location: Hall F1
    Abstract Poster Presenter: John Tesser, MD, FACP, MACR – Arizona Arthritis & Rheumatology Associates
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2279: Long-Term Prevention of RA in high-risk individuals after a 6-Month Placebo-Controlled Intervention with Abatacept -The ARIAA Trial
    Location: Hall F1
    Abstract Poster Presenter: Koray Tascilar, MD – Friedrich Alexander University of Erlangen Nuremberg, Universitätsklinikum Erlangen Department of Medicine-3 Rheumatology and Immunology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2280: Changes of B Cell Subsets During Treatment with Abatacept in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Lazaros Sakkas, MD, PhD, DM, FRCP – IASO General Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2281: Effectiveness of Upadacitinib in Patients with Rheumatoid Arthritis in Canadian Real-World Practice: Final Results from the CLOSE-UP Post-Marketing Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Louis Bessette, MD, MSc – Centre de l'Ostéoporose et de Rhumatologie de Québec
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2282: Effect of Online Continuing Education on Advancing Care for Rheumatoid Arthritis: A Real-World Outcome Analysis
    Location: Hall F1
    Abstract Poster Presenter: Nimish Mehta, PhD,MBA – Medscape
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2283: Arrhythmia Risk in Diabetic Rheumatoid Arthritis Patients: Comparative Analysis of IL-6 Inhibitors versus TNF-α Inhibitors
    Location: Hall F1
    Abstract Poster Presenter: Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2284: Cardiovascular Outcomes in Diabetic Rheumatoid Arthritis Patients: TNF-α Inhibitors versus IL-6 Inhibitors
    Location: Hall F1
    Abstract Poster Presenter: Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2285: Synovium-on-a-chip – Development of a Humanized Rheumatoid Arthritis Model that Mimics Disease and Patient Biological Heterogeneity
    Location: Hall F1
    Abstract Poster Presenter: Theresa Wampler Muskardin, MD – Hospital for Special Surgery, Weill Cornell Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2286: Association of Semaglutide Prescription with Improved Joint Outcomes in Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Yazin Hindosh, BS (he/him/his) – University of Arizona College of Medicine Tucson
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2287: Interpretable Ensemble Machine Learning Explaining Nonadherence and the Risk of Nonpersistence of Targeted Disease-Modifying Antirheumatic Agents in Older Adults with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Yinan Huang, PhD, MS – Department of Pharmacy Administration, University of Mississippi
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2288: Efficacy of Ivarmacitinib in Patients with Moderate-to-severe Rheumatoid Arthritis Stratified by Baseline Characteristics: A Post-hoc Study of a Phase III Clinical Trial
    Location: Hall F1
    Abstract Poster Presenter: Yuan Xue, MD – Zhongshan Hospital Xiamen University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2289: Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Disease Activity in Patients with Rheumatoid Arthritis: A Pilot Study
    Location: Hall F1
    Abstract Poster Presenter: Yuichiro Fujieda, MD,PhD – Hokkaido University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2229: National Multicenter study of Baricitinib in Rheumatoid Arthritis - Interstitial Lung Disease: effectiveness and progressive lung disease
    Location: Hall F1
    Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2261: Palindromic Rheumatism and Predictors of Progression to Rheumatoid Arthritis: Experience from a Tertiary Care Center in Northern India
    Location: Hall F1
    Abstract Poster Presenter: Sryla Punjadath, MBBS, MD (she/her/hers) – All India Institute of Medical Sciences, Rishikesh
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2247: A Pilot Study to Identify Novel Autoantibody Biomarkers in Rheumatoid Arthritis (RA) Patients Using Immunome Protein Array
    Location: Hall F1
    Abstract Poster Presenter: Margaret Ma, MD,PhD – National University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2242: Analysis of Bronchoalveolar Fluid Cytokine Profile as a Way to Understand the Lung Disease Associated with Systemic Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Ivanna Romankevych, MD, PhD – Cincinnati Children's Hospital Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2249: Evaluation of a Screening Tool for Identifying Risk of Subclinical Interstitial Lung Disease in Rheumatoid Arthritis Patients Treated with Targeted Therapies
    Location: Hall F1
    Abstract Poster Presenter: Marina Pavía Pascual, MD – Hospital General Universitario Gregorio Marañón
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2236: Treatment-induced autoantibodies in Rheumatoid Arthritis patients receiving anti-TNF inhibitors or JAK inhibitors
    Location: Hall F1
    Abstract Poster Presenter: EVRIPIDIS KALTSONOUDIS, MD (he/him/his) – Medical School of Ioannina
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2259: Lung Transplant Outcomes in Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis and Meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Saud AlHajeri, MBChB – UBC
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2258: Clinical Associations of Pulmonary Hypertension in RA Patients with and Without Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Sanjita Gowda, MD (she/her/hers) – Cedars-Sinai Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2232: Risk factors for hospitalizations in a large, contemporary rheumatoid arthritis patient cohort
    Location: Hall F1
    Abstract Poster Presenter: Argyro Lazarini, MSc (she/her/hers) – National and Kapodistrian University of Athens
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2228: COVID-19 Outcomes in Rheumatoid Arthritis Patients Prescribed Biologic vs. Conventional DMARDs: A Propensity-Matched Analysis
    Location: Hall F1
    Abstract Poster Presenter: Chase Verdugo, -None- (he/him/his) – University of Arizona College of Medicine Tucson
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2250: Clinical and Serological Predictors of Interstitial Lung Disease in Rheumatoid Arthritis: Are Anti-Citrullinated Protein Antibodies Truly Relevant?
    Location: Hall F1
    Abstract Poster Presenter: Martí Aguilar Coll, MD – Hospital Universitari de Bellvitge
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2252: Association Between Frailty and Survival Among Older Adults with Rheumatoid Arthritis and Lung Cancer
    Location: Hall F1
    Abstract Poster Presenter: Michelle Nguyen, MD – University of Washington
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2243: Differences In GDF-15 Levels In Rheumatoid Arthritis Patients With Remission Or Mild Disease Activity Are Associated With Fewer Depressive Symptoms: Clinical Data And Bioinformatic Analysis
    Location: Hall F1
    Abstract Poster Presenter: Jessica Roldan Ortega, MD – INSTITUTO NACIONAL DE CARDIOLOGIA
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2245: Add-on of Coronary Artery Calcium Score Significantly Improves the Risk Prediction of Cardiovascular Diseases in Patients with Rheumatoid Arthritis: From a Real-world Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Lie Dai, PhD – Department of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2235: Proportion of Early Rheumatoid Arthritis Patients with Improved, Stable, or Worsened Lung Function Over 1-Year: Results from a Multicenter, Prospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Erica Mulcaire-Jones, MD – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2237: Safety of DMARD therapy in veterans with rheumatoid arthritis following melanoma diagnosis: a survival analysis
    Location: Hall F1
    Abstract Poster Presenter: Gabriella Girolami, MS-4 – University of Washington
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2254: Association of Disease Activity with Insomnia, Depression, and Fatigue in Patients with Rheumatoid Arthritis: A Multicenter Prospective Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Misako Higashida-Konishi, MD – NHO Tokyo Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2262: Assessment of Small Airway Disease in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Stéphane HILLIQUIN, n/a – Département de Rhumatologie, Hôpital Cochin, Assistance publique des Hôpitaux de Paris, Université Paris-Cité, Paris, France
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2234: Early Sustained Remission Resulted in Superior Long-term Patient-Reported Outcomes in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Cheuk Yin Tam, n/a – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2256: Improved Outcomes of Acute Myocardial Infarction Among Patients with Rheumatoid Arthritis: A Propensity Matched National Study
    Location: Hall F1
    Abstract Poster Presenter: Qurat Ul Ain, MD (she/her/hers) – Medstar Georgetown University hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2233: Spatial Multi-omics Demonstrates Shared Immune States Across Autoimmune Diseases and Target Tissues in the Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Diseases Network (AMP AIM)
    Location: Hall F1
    Abstract Poster Presenter: Caleb Marlin, PhD – Oklahoma Medical Research Foundation
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2241: RADAR: A Deep Learning Pipeline for Automated Scoring of Joint Damage in Rheumatoid Arthritis Radiographs
    Location: Hall F1
    Abstract Poster Presenter: Hugo PENSEC, MSc – CHRU Brest
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2231: Inverse Correlation Between Neutrophil Activation and Rheumatoid Factor Concentrations in Rheumatoid Arthritis (RA)
    Location: Hall F1
    Abstract Poster Presenter: Anne-Christine Bay-Jensen, PhD, MSc – Nordic Bioscience
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2263: Comparison of a Patient-Reported Disease Activity Measure with Physician-Based Indices in Rheumatoid Arthritis Patients in Nigeria
    Location: Hall F1
    Abstract Poster Presenter: Uchechukwu Tralagba, MBBS (she/her/hers) – University of Port Harcourt Teaching Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2260: Generative AI model identifies patients with Rheumatoid Arthritis (RA) months prior the diagnosis date: results from a large real-world RA cohort
    Location: Hall F1
    Abstract Poster Presenter: Shant Ayanian, MD, MS – Mayo Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2230: Racial and Ethnic Disparities in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Their Impact on Antifibrotic Therapy
    Location: Hall F1
    Abstract Poster Presenter: Andrea Galecio Chao, MD (she/her/hers) – Baylor College of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2238: Impact of Type 2 Diabetes on Cardiovascular and Renal Outcomes in Rheumatoid Arthritis: Insights from a Large-Scale Multi-Center Analysis
    Location: Hall F1
    Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2246: Different Populations, Different SDAI Cut-Off? A Proposal for a New Remission Threshold in Brazilian RA Patients from a National Multicenter Study
    Location: Hall F1
    Abstract Poster Presenter: Lucas Pires, MD – State University of Campinas (UNICAMP) - Brazil
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2257: Impact of Family History of RA in Patients Evaluated for Arthralgia: A Comprehensive Analysis of the Reuma-check Cohort
    Location: Hall F1
    Abstract Poster Presenter: Rodrigo Garcia Salinas, MD – Hospital Italiano La Plata
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2244: Bone Mineral Density Trajectories and Fracture Risk in Rheumatoid Arthritis: A 7-Year Longitudinal Analysis Using Group-Based Trajectory Modeling
    Location: Hall F1
    Abstract Poster Presenter: Kei Hirose, MD – Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2255: Diagnostic Accuracy of Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Pannathorn Nakaphan, MD (he/him/his) – Weiss Memorial Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2248: Elevated Anti-PAD Autoantibodies in a Singaporean Chinese Rheumatoid Arthritis (RA) Cohort with Rheumatoid Factor (RF) and Anti-Citrullinated Protein Antibodies (ACPA) Positivity: A Case-control Exploratory Study
    Location: Hall F1
    Abstract Poster Presenter: Margaret Ma, MD,PhD – National University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2264: Male Sex and Obesity Are Risk Factors for Sarcopenia in RA: Korea National Health and Nutrition Survey 2008–2011
    Location: Hall F1
    Abstract Poster Presenter: Yoon-Jeong Oh, MD – Uijeongbu Eulji Medical Center
  • Wednesday, Oct 29th
    9:30 AM - 11:00 AM Central Time
    29W07: Abstracts: Rheumatoid Arthritis – Treatment II: Phenotyping and Personalization
    Location: W190A-B
    Abstract Moderator: Andreas Kerschbaumer, MD, PhD – Medical University of Vienna / Stanford University
    Abstract Moderator: Melissa Griffith, MD, RhMSUS – University of Colorado
     CE: 0.00
  • Wednesday, Oct 29th
    9:30 AM - 9:45 AM Central Time
    2639: Gut Microbiome Signatures Forecast Clinical Response to Methotrexate in Treatment-Naïve Early Rheumatoid Arthritis
    Location: W190A-B
    Presenting Author: VINOD K. GUPTA, PhD – Mayo Clinic
  • Wednesday, Oct 29th
    9:45 AM - 10:00 AM Central Time
    2640: Effectiveness of Biological and Target-Synthetic Treatment in Patients with Rheumatoid Arthritis and Kidney Dysfunction: A Large Prospective Registry Study
    Location: W190A-B
    Presenting Author: Sho Fukui, MD, MPH – Brigham and Women's Hospital / Kyorin University Hospital
  • Wednesday, Oct 29th
    10:00 AM - 10:15 AM Central Time
    2641: Cizutamig, a BCMA T-cell engager: preclinical to clinical translation of design optimization for the treatment of autoimmune diseases
    Location: W190A-B
    Presenting Author: Ricardo Grieshaber-Bouyer, MD, PhD – University Hospital Erlangen
  • Wednesday, Oct 29th
    10:15 AM - 10:30 AM Central Time
    2642: Impact of Rheumatoid Arthritis Therapeutic Classes on Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism: A Population-Based Cohort Study
    Location: W190A-B
    Presenting Author: Bindee Kuriya, MD, MS – University of Toronto - Toronto
  • Wednesday, Oct 29th
    10:30 AM - 10:45 AM Central Time
    2643: Microbiome Signatures in RA Treatment: Personalizing Methotrexate Therapy
    Location: W190A-B
    Presenting Author: Renuka Nayak, MD, PhD – University of California, San Francisco (UCSF)
  • Wednesday, Oct 29th
    10:45 AM - 11:00 AM Central Time
    2644: Single Cell RNA-seq Profiling Reveals a Blood Monocyte Phenotype Associated with Response to TNF Inhibitor Therapy in RA Patients
    Location: W190A-B
    Presenting Author: Kathryne Marks, PhD – Brigham and Women's Hospital
  • Wednesday, Oct 29th
    11:30 AM - 1:00 PM Central Time
    29W16: Abstracts: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes III: Long Live (Comorbidity and Outcomes)
    Location: W183A-C
    Abstract Moderator: Timothy Wilson, MD – Thomas Jefferson University
    Abstract Moderator: Austin Wheeler, MD (he/him/his) – University of Nebraska Medical Center
     CE: 0.00
  • Wednesday, Oct 29th
    11:30 AM - 11:45 AM Central Time
    2681: Derivation and Validation of Inflammation-Adjusted Lipid Measures to Improve Cardiovascular Risk Prediction in Rheumatoid Arthritis
    Location: W183A-C
    Presenting Author: Tate Johnson, MD – University of Nebraska Medical Center
  • Wednesday, Oct 29th
    11:45 AM - 12:00 PM Central Time
    2682: Methotrexate use and higher age impair humoral response against the recombinant herpes zoster vaccine (RZV) in Rheumatoid Arthritis: a prospective, randomized, placebo-controlled trial
    Location: W183A-C
    Presenting Author: Ana Medeiros-Ribeiro, MD, PhD (she/her/hers) – Hospital das Clinicas da Faculdade de Medicina da USP
  • Wednesday, Oct 29th
    12:00 PM - 12:15 PM Central Time
    2683: Association of Genetic Risk for Pain Intensity with Longitudinal Disease Activity in Rheumatoid Arthritis
    Location: W183A-C
    Presenting Author: Stevie Barry, MBChB – University of Pennsylvania Health System Program
  • Wednesday, Oct 29th
    12:15 PM - 12:30 PM Central Time
    2684: Multimodal Analysis Revealed Altered Brain Connectivity Patterns and Neuroinflammatory Processes in the Background of Difficult-To-Treat Rheumatoid Arthritis
    Location: W183A-C
    Presenting Author: Lilla Dr. Gunkl-Toth, MD – University of Pécs; Semmelweis University
  • Wednesday, Oct 29th
    12:30 PM - 12:45 PM Central Time
    2685: Assessing for Racial/ethnic Variability in U.s.-fraxtm Performance Among Older Adult Women with Rheumatoid Arthritis in the United States
    Location: W183A-C
    Presenting Author: Rachel Elam, MD, MS (she/her/hers) – Augusta University
  • Wednesday, Oct 29th
    12:45 PM - 1:00 PM Central Time
    2686: Impact of autoimmunity, disease activity and treatment on the time course of bone density, microstructure and biomechanics in inflammatory arthritis.
    Location: W183A-C
    Presenting Author: Koray Tascilar, MD – Friedrich Alexander University of Erlangen Nuremberg, Universitätsklinikum Erlangen Department of Medicine-3 Rheumatology and Immunology